Ruxolitinib | High-Quality Pharmaceutical Reference Standard
Ruxolitinib API is a selective JAK1/JAK2 inhibitor used in the treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease.
Ruxolitinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 14